Epicutaneous Staphylococcus aureus induces IL-36 to enhance IgE production and ensuing allergic disease
Garrett J. Patrick,Haiyun Liu,Martin P. Alphonse,Dustin A. Dikeman,Christine Youn,Jack C. Otterson,Yu Wang,Advaitaa Ravipati,Momina Mazhar,George Denny,Roger V. Ortines,Emily Zhang,Robert J. Miller,Carly A. Dillen,Qi Liu,Sabrina J. Nolan,Kristine Nguyen,LeeAnn Marcello,Eric M. Wier,Yan Zhang,Gary Caviness,Alexander C. Klimowicz,Diane V. Mierz,Jay S. Fine,Guangping Sun,Raphaela Goldbach-Mansky,Alina I. Marusina,Alexander A. Merleev,Emanual Maverakis,Luis A. Garza,Joshua D. Milner,Peisong Gao,Meera Ramanujam,Ernest L. Raymond,Nathan K. Archer,Lloyd S. Miller,Danh C. Do
DOI: https://doi.org/10.1172/jci143334
IF: 19.456
2021-03-01
Journal of Clinical Investigation
Abstract:IgE induced by type 2 immune responses in atopic dermatitis is implicated in the progression of atopic dermatitis to other allergic diseases, including food allergies, allergic rhinitis, and asthma. However, the keratinocyte-derived signals that promote IgE and ensuing allergic diseases remain unclear. Herein, in a mouse model of atopic dermatitis–like skin inflammation induced by epicutaneous <i>Staphylococcus aureus</i> exposure, keratinocyte release of IL‑36α along with IL-4 triggered B cell IgE class-switching, plasma cell differentiation, and increased serum IgE levels—all of which were abrogated in IL-36R–deficient mice or anti-IL‑36R–blocking antibody–treated mice. Moreover, skin allergen sensitization during <i>S</i>. <i>aureus</i> epicutaneous exposure-induced IL-36 responses was required for the development of allergen-specific lung inflammation. In translating these findings, elevated IL‑36 cytokines in human atopic dermatitis skin and in IL‑36 receptor antagonist–deficiency patients coincided with increased serum IgE levels. Collectively, keratinocyte-initiated IL‑36 responses represent a key mechanism and potential therapeutic target against allergic diseases.
medicine, research & experimental